- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
The Trust Imperative: Defining and Building Trust in Pharma
Senior editor Fran Pollaro and Morten Nielsen, senior partner for the life sciences practice at Wittkieffer, embark on an insightful exploration of trust in the pharmaceutical industry, discussing its measurement, improvement, and critical role in governance, culture, leadership, and organizational structure, while offering practical advice for industry leaders on embedding transparency, inclusion, and accountability into daily operations.
This Pharma 50 companion episode delves into the vital topic of trust within the pharmaceutical industry. Morten Nielsen, senior partner for the life sciences practice at Wittkieffer, dissects the concept, drawing on parallels to Maslow's hierarchy of needs, and discusses practical methods for measuring and operationally improving trust. This episode is a must-listen for those interested in understanding the current state and future evolution of trust in the pharmaceutical sector, an industry where trust forms a fundamental pillar for delivering on its mission statement.
About the speaker
A senior partner for the Life Sciences Practice at WittKieffer, Morten Nielsen (he/him) has more than three decades of direct, relevant industry experience. Most recently he has spent over 10 years in executive search, including various global leadership responsibilities. He has recruited board directors, CEOs, and other C-level executives across most functional areas inclusive of R&D, medical, clinical, commercial, operations, quality and regulatory affairs for organizations in healthcare, medical device, diagnostic, pharmaceuticals and biotech.
Prior to entering the executive search industry, Morten spent over 20 years working within the healthcare and life sciences industries. Approximately half of his industry career was spent in Europe. He began his career with Pharmacia Diagnostics (now GE), where he held Account Representative and Product Specialist roles. He also held roles in marketing with Baxter, general management roles with Rhone-Poulenc Rorer (now Sanofi), and Wyeth (now Pfizer) prior to moving into medical devices with Boston Scientific. His last role in the industry before moving into executive search was as Corporate Vice President and Group President, Life Sciences with STERIS Corporation.
Morten currently serves as Chair, Emeritus of the global board of directors of the Association of Executive Search and Leadership Consultants (AESC).
About the Pharm Exec Podcast
The editors of Pharmaceutical Executive bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
